A collection of news and information related to Sanofi-Aventis published by this site and its partners.
Displaying items 1-12 of 17 » View all items1 2 Next >
California stands to lose about $180 million in medical and scientific research funding under sequestration cuts, the most of any state, according to a group of biomedical researchers. Sequestration, which went into effect March 1 after Congress...
A new study suggests that the 6% to 10% of Americans who use prescription sleep medications such as zolpidem (Ambien), temazepam (Restoril), eszopiclone (Lunesta) and zaleplon (Sonata) are more likely to develop cancer, and far more likely to die...
Tags: Lymphoma, Arts and Culture, Ambien (drug), Asthma, Flu
In December of 2007, I was diagnosed with Type 2 diabetes. I initially felt scared and confused, but then I committed to educating myself about diabetes and worked with my doctor to determine the overall diabetes treatment plan that was right for me....
There was a time when BlackBerrys grew wild. They were everywhere: boardrooms, restaurants and kitchen tables. The dark little devices would vibrate every time a new e-mail arrived, delivering a tiny thrill that millions of employees came to both...
L.A. UnleashedTRENTON, N.J. â Pfizer Inc. said Wednesday its animal health unit and the American Kennel Club Canine Health Foundation entered an exclusive partnership on new areas of research on dog diseases and treatments. Pfizer said the goal is to strengthen......
Booster ShotsThe first injectable vaccines against the pandemic H1N1 influenza virus have been shipped, about two weeks earlier than expected. "The first truck left today" from a factory in Swiftwater, Pa., Chris Viehbacher, chief executive of the French...
Booster ShotsAbout this time last year, we were reporting on the failure of several investigational weight-loss medications. They included Sanofi-Aventis' rimonabant as well as two other drugs that aimed to work by blocking cannabinoid receptors in the brain. However,...
Booster ShotsDr. Margaret A. Hamburg, commissioner of the Food and Drug Administration, sent a letter to all U.S. physicians today thanking them for their help in combating the pandemic H1N1 influenza virus and reassuring them about the safety of the vaccine......
Booster ShotsVaccine manufacturer Sanofi-Aventis is recalling 800,000 doses of vaccine against the pandemic H1N1 virus meant for children younger than 3 because the vaccine has lost potency since it was shipped from the factory. "This is non-safety related, but is...
Booster ShotsParis-based drug giant Sanofi-Aventis made waves today when it announced the $1.9 billion acquisition of Chattem Inc., humble maker of Selsun Blue shampoo and Gold Bond medicated powder. Business pundits wondered what a high-end international...
Los Angeles TimesVaccine maker MedImmune has voluntarily recalled 13 lots of vaccine against the pandemic H1N1 influenza because they have lost some potency since they were manufactured, the company said Tuesday. "This is not a safety issue," Norman Baylor, director of...
Booster ShotsAn experimental drug called cabazitaxel increases survival by 30% in men with advanced prostate cancer that has become resistant to all other forms of treatment, researchers will report Friday at a San Francisco meeting called the 2010 Genitourinary...
Mar 22, 2013 |Story| Los Angeles Times
Feb 28, 2012 |Story| Los Angeles Times
May 15, 2011 |Story| Los Angeles Times
Dec 5, 2010 |Story| Los Angeles Times
Sep 8, 2010 | Los Angeles Times
Sep 29, 2009 | Los Angeles Times
Oct 28, 2009 | Los Angeles Times
Nov 10, 2009 | Los Angeles Times
Dec 15, 2009 | Los Angeles Times
Dec 21, 2009 | Los Angeles Times
Dec 23, 2009 |Story| Los Angeles Times
Mar 4, 2010 | Los Angeles Times
Original site for Sanofi-Aventis topic gallery.